|   | a)     |   | Designed      such disclosure controls and procedures or caused such disclosure controls      and procedures to be designed under our supervision, to ensure that      material information relating to China Healthcare Acquisition Corp.,      including its consolidated subsidiaries, is made known to us by others      within those entities, particularly during the period in which this report      is being prepared; |
|--------|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |   |                                                                                                                                                                                                                                                                                                                                                                                                                            |
|   | b)     |   | Evaluated      the effectiveness of China Healthcare Acquisition Corp.’s disclosure      controls and procedures and presented in this report our conclusions about      the effectiveness of the disclosure controls and procedures, as of the end      of the period covered by this report based on such evaluation;      and                                                                                          |
|   |   |   |                                                                                                                                                                                                                                                                                                                                                                                                                            |
|   | c)     |   | Disclosed      in this report any changes in China Healthcare Acquisition Corp.’s      internal control over financial reporting that occurred during China      Healthcare Acquisition Corp.’s most recent fiscal year that has materially      affected, or is reasonably likely to materially affect, China Healthcare      Acquisition Corp.’s internal control over financial    reporting.              |

|                          | a)                                            |   | All      significant deficiencies and material weaknesses in the design or      operation of internal control over financial reporting which are      reasonably likely to adversely affect China Healthcare Acquisition Corp.’s      ability to record, process, summarize and report financial information;      and |
|-------------------------------|-----------------------------------------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                          |                                          |   |                                                                                                                                                                                                                                                                                                                         |
|                          | b)                                            |   | Any      fraud, whether or not material, that involves management or other      employees who have a significant role in China Healthcare Acquisition      Corp.’s internal controls over financial reporting.                                                                                                         |
|                          |                                          |   |                                                                                                                                                                                                                                                                                                                         |   |
|                          |                                          |   |
| Date:      May 15, 2009  | /s/      Alwin Tan                       |   |
|                          | Alwin      Tan, Chief Executive Officer  |   |
|                          |                                          |   |

----